RARE DISEASERESEARCH ATLAS

ORPHA:91412

Marcus-Gunn syndrome

high confidenceDisorder

Also known as: Jaw-winking syndrome · Mandibulo-palpebral synkinesis-ptosis syndrome · Marcus-Gunn phenomenon

Publications

628

80.3th percentile

Trials

0

Interventional, condition-specific

Researchers

963

Distinct authors in sample

Gene link

Readiness

1/6

Stages with a signal

Clinical definition (Orphanet)

A rare ophthalmic disorder characterized by ptosis associated with pterygoid-levator synkinesis (also called jaw-winking).

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (7)

Marcus Gunn Phenomenon · Marcus Gunn phenomenon · Marcus Gunn syndrome · Maxillopalpebral synkinesis · jaw-winking · jaw-winking syndrome · mandibulo-palpebral synkinesis-ptosis syndrome

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

1/6 stages with a signal

Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    628 matched papers (222 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

628

628 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

628 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

222 in the last 10 years · high confidence · 80.3th percentile (publications denominator)

Phrase hits: 628 · MeSH hits: 13

Open Europe PMC search

Who's working on it?

963

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Zhang J6 papers · 2023

    Xi'an BRIGHT Eye Hospital, Xi'an, Shaanxi 710000, China.

    Papers in Europe PMC
  2. 02
    Liang H5 papers · 2022

    Xi'an BRIGHT Eye Hospital, Xi'an, Shaanxi 710000, China.

    Papers in Europe PMC
  3. 03
    Zhang H5 papers · 2025

    Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, China.

    Papers in Europe PMC
  4. 04
    Qiao Y4 papers · 2020

    Shaanxi Provincial Eye Research Institute and Xi'an Eye Hospital Xi'an, Shaanxi 710002, China.

    Papers in Europe PMC
  5. 05
    Rajabi MT4 papers · 2026

    Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

    Papers in Europe PMC
  6. 06
    Ye J4 papers · 2026

    Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, China. yejuan@zju.edu.cn.

    Papers in Europe PMC
  7. 07
    Alam MS3 papers · 2024

    Orbit, Oculoplasty, Reconstructive and Aesthetic Services, Aditya Birla Sankara Nethralaya, (A Unit of Medical Research Foundation, Chennai) Kolkata, West Bengal, India.

    Papers in Europe PMC
  8. 08
    Alsuhaibani AH3 papers · 2025

    Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

    Papers in Europe PMC
  9. 09
    Bai P3 papers · 2025

    Department of Ophthalmology, Affiliated Hospital of Yunnan University, Second People's Hospital of Yunnan Province, Key Laboratory of Yunnan Province, Yunnan Eye Institute.

    Papers in Europe PMC
  10. 10
    Li J3 papers · 2025

    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name. 1 observational study did — shown below because natural-history and cohort work can be an important step toward a trial.

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

high confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Observational and natural-history studies

1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Marcus-Gunn syndrome" OR "Jaw-winking syndrome" OR "Mandibulo-palpebral synkinesis-ptosis syndrome" OR "Marcus-Gunn phenomenon" OR "Marcus Gunn Phenomenon" OR "Marcus Gunn syndrome" OR "Maxillopalpebral synkinesis" OR "jaw-winking"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Marcus Gunn phenomenon

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Marcus-Gunn syndrome" OR "Jaw-winking syndrome" OR "Mandibulo-palpebral synkinesis-ptosis syndrome" OR "Marcus-Gunn phenomenon" OR "Marcus Gunn Phenomenon" OR "Marcus Gunn syndrome" OR "Maxillopalpebral synkinesis" OR "jaw-winking"

Study-type breakdown: 0 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T04:02:04.717Z